<DOC>
	<DOCNO>NCT00040833</DOCNO>
	<brief_summary>RATIONALE : Acupuncture acupressure may help relieve moderate severe pain associate stage III stage IV pancreatic cancer . PURPOSE : Phase II trial study effectiveness acupuncture accupressure treat patient moderate severe pain associate stage III stage IV pancreatic cancer .</brief_summary>
	<brief_title>Acupuncture Acupressure Treating Patients With Moderate Severe Pain Related Stage III Stage IV Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Assess effect acupuncture acupressure pain , sedation , use opiate medication patient moderate severe pain related stage III IV pancreatic cancer . - Determine whether controlled trial therapy warrant patient population . - Provide data aid design warrant study therapy patient population . OUTLINE : Patients receive acupuncture treatment comprise 20 minute needle insertion arm abdomen depth use traditional Chinese medicine approximately day 4 , 7 , 11 , 14 . After acupuncture treatment , acupuncturist applies/reapplies acupressure device insert 2-6 small needle ( stud ) abdomen ( held place surgical tape ) tap tiny metal ball 3 point ear . Patients caregiver instruct administer acupressure press ear point ( metal ball ) 1-2 minute per point move semi-permanent abdominal needle small circular movement finger , rate 2-3 cycle per second , 1-2 minute per point , upon wake morning early afternoon . Patients caregiver also instruct stimulate `` rescue point '' ( Shenmen auricular point ) patient experience pain exacerbation time day . Patients respond well acupuncture offer treatment . Pain assess use numerical rating scale approximately day 1-4 , 7 , 11 , 14-17 . Sedation assess use Profile Mood States ( POMS ) approximately day 3 17 . Analgesic medication use assess approximately day 1-3 15-17 . PROJECTED ACCRUAL : A total 10-29 patient accrue study within approximately 2 year .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage III IV primary pancreatic cancer At least 4 day since prior change type pain medication No change dose longacting analgesic Actual dose need ( PRN ) pain medication may vary One follow pain score : Pain score least 4 scale 0 10 A score least 54 88 combine relevant Profile Mood States ( POMS ) subscales ( Vigor , Fatigue , Confusion ) evidence sedation result cause opiate medication patient report use PRN opiates least 4 past 7 day ( patient eligible study basis POMS score must take PRN medication ) PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Not specify Life expectancy : At least 4 week Hematopoietic : Absolute neutrophil count least 500/mm^3 Platelet count least 20,000/mm^3 Hepatic : INR great 2.5 Renal : Not specify Cardiovascular : No heart valve dysfunction Other : No uncontrolled infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior gemcitabine unless documented disease progression Concurrent chemotherapy ( except gemcitabine ) allow Endocrine therapy : Not specify Radiotherapy : At least 3 week since prior radiotherapy No concurrent radiotherapy Surgery : At least 1 week since prior epidural analgesia , celiac plexus block , thoracoscopic open splanchnicectomy No concurrent epidural analgesia , celiac plexus block , thoracoscopic open splanchnicectomy Other : See Disease Characteristics At least 3 month since prior acupuncture Concurrent experimental treatment allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>pain</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>